rs1042522
|
|
|
0.090 |
GeneticVariation |
BEFREE |
Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis.
|
30126398 |
2018 |
rs754332870
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Analysis of the KRAS gene showed only a G12C variation in one large cell carcinoma (LCC) patient, whereas variants were not found in adenocarcinoma (ADC) and squamous cell carcinoma (SCC) cases.
|
30048458 |
2018 |
rs762846821
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We also studied genetically induced SCCs that expressed G12D mutant Kras (Kras G12D) but were deficient for p53.
|
26168291 |
2015 |
rs1042522
|
|
|
0.090 |
GeneticVariation |
BEFREE |
In this study, we analyzed the association of TP53 Pro72Arg polymorphism with squamous cell carcinoma of oral tongue (SCCOT) and esophagus (ESCC) in India.
|
25436609 |
2014 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
In this study, we analyzed the association of TP53 Pro72Arg polymorphism with squamous cell carcinoma of oral tongue (SCCOT) and esophagus (ESCC) in India.
|
25436609 |
2014 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
In this study, we analyzed the association of TP53 Pro72Arg polymorphism with squamous cell carcinoma of oral tongue (SCCOT) and esophagus (ESCC) in India.
|
25436609 |
2014 |
rs1042522
|
|
|
0.090 |
GeneticVariation |
BEFREE |
P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
|
23683469 |
2013 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
|
23683469 |
2013 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
|
23683469 |
2013 |
rs1042522
|
|
|
0.090 |
GeneticVariation |
BEFREE |
Polymorphism Arg72Pro of p53 confers susceptibility to squamous cell carcinoma of lungs in a North Indian population.
|
23317414 |
2013 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Polymorphism Arg72Pro of p53 confers susceptibility to squamous cell carcinoma of lungs in a North Indian population.
|
23317414 |
2013 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Polymorphism Arg72Pro of p53 confers susceptibility to squamous cell carcinoma of lungs in a North Indian population.
|
23317414 |
2013 |
rs587783064
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Therefore, the FGFR4 Gly388Arg polymorphism and TP53 mutations, as well as their combinations, are excellent predictors of the prognosis for OSCC patients.
|
20127014 |
2010 |
rs1042522
|
|
|
0.090 |
GeneticVariation |
BEFREE |
In a large prospective cohort, p53 Arg72Pro Pro/Pro was associated with a 2-fold increased risk of death in all esophageal cancers, whereas MDM2 T309G G/G was associated with a 7-fold increased risk of death in squamous cell carcinoma.
|
19383811 |
2009 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
In a large prospective cohort, p53 Arg72Pro Pro/Pro was associated with a 2-fold increased risk of death in all esophageal cancers, whereas MDM2 T309G G/G was associated with a 7-fold increased risk of death in squamous cell carcinoma.
|
19383811 |
2009 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
In a large prospective cohort, p53 Arg72Pro Pro/Pro was associated with a 2-fold increased risk of death in all esophageal cancers, whereas MDM2 T309G G/G was associated with a 7-fold increased risk of death in squamous cell carcinoma.
|
19383811 |
2009 |
rs1042522
|
|
|
0.090 |
GeneticVariation |
BEFREE |
We evaluated the effect of MDM2 SNP309 and its interaction with the p53 Arg72Pro polymorphism on pigmentary phenotypes and skin cancer risk in a nested case-control study within the Nurses' Health Study (NHS) among 219 melanoma cases, 286 squamous cell carcinoma (SCC) cases, 300 basal cell carcinoma (BCC) cases, and 873 controls, and among controls from other studies.
|
18814047 |
2009 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
We evaluated the effect of MDM2 SNP309 and its interaction with the p53 Arg72Pro polymorphism on pigmentary phenotypes and skin cancer risk in a nested case-control study within the Nurses' Health Study (NHS) among 219 melanoma cases, 286 squamous cell carcinoma (SCC) cases, 300 basal cell carcinoma (BCC) cases, and 873 controls, and among controls from other studies.
|
18814047 |
2009 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
We evaluated the effect of MDM2 SNP309 and its interaction with the p53 Arg72Pro polymorphism on pigmentary phenotypes and skin cancer risk in a nested case-control study within the Nurses' Health Study (NHS) among 219 melanoma cases, 286 squamous cell carcinoma (SCC) cases, 300 basal cell carcinoma (BCC) cases, and 873 controls, and among controls from other studies.
|
18814047 |
2009 |
rs1042522
|
|
|
0.090 |
GeneticVariation |
BEFREE |
Our data indicate that the TP53 Arg72Pro polymorphism increases the risk for squamous-cell carcinoma mainly in heavy smokers.
|
17059853 |
2007 |
rs1131691014
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Our data indicate that the TP53 Arg72Pro polymorphism increases the risk for squamous-cell carcinoma mainly in heavy smokers.
|
17059853 |
2007 |
rs878854066
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Our data indicate that the TP53 Arg72Pro polymorphism increases the risk for squamous-cell carcinoma mainly in heavy smokers.
|
17059853 |
2007 |
rs1057520001
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The results for the p21 Ser31Arg polymorphism suggested that 31Ser is a moderate-risk allele for squamous-cell carcinoma.
|
17059853 |
2007 |
rs886039484
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The results for the p21 Ser31Arg polymorphism suggested that 31Ser is a moderate-risk allele for squamous-cell carcinoma.
|
17059853 |
2007 |
rs1042522
|
|
|
0.090 |
GeneticVariation |
BEFREE |
We evaluated the association of the Arg72Pro polymorphism with skin cancer risk among Caucasians in a nested case-control study within the Nurses' Health Study (NHS) (219 melanoma, 286 squamous cell carcinoma (SCC), and 300 basal cell carcinoma (BCC) and 874 controls).
|
16739124 |
2006 |